When.com Web Search

  1. Ads

    related to: contrave vs qsymia xenical 5 pack dosage range
    • Dosing Information

      View Dosing Information & Support

      Including Our Quick Start Guide.

    • How It Works

      A Treatment Option That Works With

      Your Body To Help Control Appetite.

Search results

  1. Results From The WOW.Com Content Network
  2. Naltrexone/bupropion - Wikipedia

    en.wikipedia.org/wiki/Naltrexone/bupropion

    In September 2014, a sustained release formulation of the drug was approved for marketing in the United States under the brand name Contrave. [8] [9] The combination was subsequently approved in the European Union in the spring of 2015, where it is sold under the name Mysimba. [5] [10] It was approved in Canada under the Contrave brand name in ...

  3. 15 Alternatives to Ozempic for Weight Loss - AOL

    www.aol.com/15-alternatives-ozempic-weight-loss...

    You’d take a 120mg dose of Xenical three times a day. In clinical trials, participants taking Xenical experienced weight loss after two weeks of treatment. This continued for six to 12 months.

  4. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    Qsymia Phentermine is a substituted amphetamine and topiramate has an unknown mechanism of action Approved for weight management (short-term) by the FDA but not the European Medicines Agency [54] 10% [55] or 8.25 kilograms (18.2 lb) [56] Naltrexone/bupropion: Contrave Approved for weight management (chronic) in the US and EU [57] 5 percent [17 ...

  5. Phentermine/topiramate - Wikipedia

    en.wikipedia.org/wiki/Phentermine/topiramate

    In the US, the drug label contains warnings for increased heart rate, suicidal behavior and ideation, glaucoma, mood and sleep disorders, creatinine elevation, and metabolic acidosis. Some of these warnings are based on historical observations in epilepsy patients taking topiramate.

  6. Adherence to weight-loss drugs is far higher with ... - AOL

    www.aol.com/news/adherence-weight-loss-drugs-far...

    Only 13% of patients who started taking Contrave from Orexigen Therapeutics and 10% of those who started on Qsymia from Vivus between 2015 and 2022 were still filling their prescriptions a year ...

  7. New Obesity Drug Is Safe (Enough) - AOL

    www.aol.com/news/2013-11-25-new-obesity-drug-is...

    For premium support please call: 800-290-4726 more ways to reach us